Earlier is Better with SLT
Andrew G. Iwach, MD
Tuesday, November 26, 2013
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Glaucoma: Meds vs. Lasers
Financial Disclosure
Primary POAG Endpoints
Treatment vs. Observation
The Glaucoma Graph
Prostaglandin Side Effects
Hyperemia More than Cosmetic
The Concept of Persistency
Therapeutic Effect vs. Time
Ongoing Clinical Investigations
SLT vs. Meds as Initial Treatment Study
Treatment Groups and Sequence of Steps
SLT vs. Medication Study
Projected Cost Comparison for OAG
Surgical Trends 1994-2010
Summary: Why SLT?
Glaucoma Center of San Francisco
No transcript for this webinar
More Information
Request info